There is a beacon of hope for patients with a rare genetic disorder called Werner Syndrome as researchers unveil a groundbreaking discovery: Nicotinamide riboside, a vitamin B3 derivative, reverses premature ageing.
Pandemic preparedness has become a global priority since COVID-19 and new diseases continue to emerge and old ones resurge; this continues to be a threat to public health and economic stability.
The Young Stroke Physicians and Researchers (YSPR) Committee, composed of young members of the European Stroke Organisation, is dedicated to promoting the involvement of young stroke physicians and researchers in the ESO and the broader field of stroke care. On behalf of the YSPR, Dr Sarah Gorey highlights some key challenges in stroke-related care, as well as recent innovations in treatment.
Researchers have made a new discovery in the fight against malaria. The study, recently published in Science, identified a new class of antibodies targeting a previously unexplored malaria parasite region.
Rare Diseases International, whose community engages with the World Health Organization, examines rare diseases and health equity, emphasising shifting the paradigm through global action.
Dr Samantha Walker, Director of Research and Innovation at Asthma + Lung UK, the leading lung charity, discusses the socioeconomic costs of lung conditions and the need for great lung health research.
Examining the macrophage populations in the synovium of patients with Rheumatoid Arthritis (RA) hopes to help uncover their role in RA pathogenesis better
Inflammatory skin diseases like psoriasis involve interactions between skin cells (keratinocytes) and immune cells, which leads to chronic inflammation, disfiguring skin lesions, and systemic effects.
In the possible event of a pandemic, the UK has secured 5 million doses of an H5 influenza vaccine to stay one step ahead of the avian influenza virus.
A new project is expected to help us understand diseases such as cancer and dementia. A major partnership involving Oxford Nanopore Technologies, UK Biobank, NHS England, Genomics England, and the UK government has made this possible.
The NHS in England has introduced a new therapy that hopes to transform the lives of hundreds of adults living with X-linked Hypophosphatemia (XLH), this rare genetic disorder causes severe bone, dental, and skeletal issues.
